.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recurrent vulvovaginal candidiasis (RVVC) presents a persistent challenge for clinicians and patients globally. Standard antifungal treatments often show reduced efficacy in recurrent cases, primarily due to the formation of fungal biofilms. Consequently, medical educators are exploring therapeutic alternatives such as probiotics. However, recent scientific focus has shifted toward postbiotics for RVVC treatment. Postbiotics include cellular components and metabolites derived from probiotics that provide health benefits without the risks associated with live microorganisms.
A recent study evaluated the anti-biofilm activity of cell-free supernatants (CFSs) derived from specific probiotic strains. Researchers tested CFSs from Lacticaseibacillus rhamnosus DM-UFMG 63, Bifidobacterium longum 5,1A, and Lactobacillus acidophilus NCFM SD 5221. They examined these against 40 Candida spp. isolates from patients suffering from RVVC. The results were significant. At a protein concentration of approximately 200μg/mL, these supernatants inhibited biofilm formation by nearly 50%.
This inhibition is vital because biofilms act as physical barriers. They protect fungal cells from the host immune system and antifungal agents. Therefore, disrupting this structure is a primary goal in managing recurrent infections. Using postbiotics for RVVC treatment offers a targeted approach to destabilizing these resilient fungal communities.
Beyond physical inhibition, postbiotics influence Candida at the genetic level. The study utilized qPCR to measure the expression of genes associated with biofilm development. Specifically, researchers observed a significant downregulation of the HWP1 and ALS3 genes in Candida albicans isolates. These genes play critical roles in adhesion and the structural integrity of the biofilm matrix. By suppressing these virulence factors, postbiotics effectively reduce the pathogenic potential of the fungi.
Furthermore, this research suggests that postbiotics could serve as a safer alternative to live probiotics. They eliminate concerns regarding microbial translocation or infections in immunocompromised individuals. As the medical community seeks more robust solutions for RVVC, postbiotics emerge as a promising pharmacological candidate.
Postbiotics are non-viable bacterial products or metabolic byproducts from probiotics, such as enzymes, peptides, and organic acids, that provide physiological benefits to the host.
They work by inhibiting the formation of biofilms and downregulating specific genes like HWP1 and ALS3, which are essential for the fungus to adhere to surfaces and grow into resistant structures.
Yes, postbiotics are generally considered safer because they do not contain live microorganisms, which reduces the risk of unintended infections or bacterial translocation, especially in sensitive patient populations.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Consuegra-Asprilla JM et al. Effect of postbiotics on biofilm formation and gene expression in Candida spp. isolates from patients with recurrent vulvovaginal candidiasis. Med Mycol. 2026 Jun 11. doi: undefined. PMID: 42275129.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new study explores postbiotics from probiotic strains like L. acidophilus as an alternative for recurrent vulvovaginal candidiasis (RVVC). Results show a 50% inhibition in Candida biofilm formation and significant downregulation of virulence genes (HWP1 and ALS3), offering a promising non-living therapy.
3 months ago
Wearable electrochemical biosensors transform athlete health management by enabling real-time, non-invasive sweat biomarker tracking for hydration, metabolic fatigue, and heat injury prevention.
Today
A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today
A recent study highlights the utility of two-dimensional speckle tracking echocardiography in assessing right atrial mechanics in OSAHS. Progressive reductions in reservoir and conduit strain, coupled with elevated contraction strain, signal early right heart remodeling correlated with apnea severity.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Yesterday
A propensity-matched study shows ultrasound-guided pulsed radiofrequency of the lumbar sympathetic ganglion is non-inferior to fluoroscopy for painful diabetic neuropathy, reducing needle passes, procedure time, and radiation exposure while achieving equal pain relief.
Today
